We recently published Small But Savage: 10 Stocks Delivering Outsized Gains. Cronos Group Inc. (NASDAQ:CRON) is one of the best performers on Tuesday. Cronos Group jumped by 7.56 percent on Tuesday to finish at $2.69 apiece as investor sentiment was fueled by its cannabis expansion program with the full acquisition of a European company. In a statement on the same day, Cronos Group Inc. (NASDAQ:CRON) said that its wholly-owned subsidiary entered into a definitive agreement to acquire CanAdelaar B.V., the ...

TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that, further to its news release dated December 1, 2025, it has issued 375,000 common shares at a deemed price of $0.035 per share to a former consultant to settle certain outstanding obligations for past services. The securities issued pursuant to the settlement are subject to a statutory hold period of four months and one day in accordance with applicable securities laws. This news relea ...

Summary of Auxly Cannabis Group Conference Call Company Overview - **Company Name**: Auxly Cannabis Group - **Ticker Symbols**: CBWTF (OTC), XLY (TSX) - **Headquarters**: Toronto, Ontario - **Industry**: Cannabis - **Market Position**: Third largest producer in Canada with approximately 6% market share [4][28] Key Points and Arguments Company Performance - **Revenue Growth**: Auxly has achieved a compound annual growth rate (CAGR) of approximately 60% since starting commercial sales in 2020 [5] - **Recent Financials**: - Generated CAD 146 million in net operating revenue over the last 12 months - Adjusted EBITDA of CAD 42 million - Free cash flow of approximately CAD 35 million before working capital adjustments [6] - **Q3 2025 Results**: - Net revenues reached CAD 39.9 million, a 20% year-over-year increase - Gross margins expanded to 56%, a 9 percentage point increase from Q3 2024 - Adjusted EBITDA of CAD 12.3 million, a 48% year-over-year increase [18] Market Dynamics - **Canadian Cannabis Market**: - Continues to grow at a rate of 5%-7% annually - Market stabilization due to the exit of companies and a shift towards asset-light models [6][7] - **Pricing Power**: Improved pricing dynamics for producers like Auxly due to strong demand and reduced competition [7] Strategic Partnerships - **Imperial Brands**: Auxly has a strategic partnership with Imperial Brands, which owns approximately 20% of Auxly's stock. This partnership is expected to provide significant advantages as new jurisdictions legalize cannabis [5][9] Product Focus and Innovation - **Product Portfolio**: Auxly specializes in dried flower, pre-rolls, and vapes, which collectively account for nearly 90% of cannabis sales in Canada [4] - **Flagship Brand**: Back 40 is the number one cannabis brand in Canada by dollar sales, with a 90% growth rate in dried flower over the last 12 months [11] - **Vape Innovations**: Auxly Charlottetown is recognized for its vapor innovation, with the Back 40 brand holding a 22% share in the all-in-one vape segment [16] Operational Excellence - **Facilities**: - Auxly Leamington is a 1.1 million sq ft cultivation facility producing about 100,000 kilograms of dried flower annually [10] - The facility is designed for high-quality production at low costs, contributing to Auxly's competitive edge [11] - **Cash Flow Management**: - Generated CAD 11 million in cash flow from operations in Q3, an 82% year-over-year increase - Strong cash flow conversion rate of 83% over the last 12 months [20] Future Outlook - **CapEx Plans**: - Anticipated increase in capital expenditures in 2026 to enhance throughput and quality at Auxly Leamington [23] - **International Expansion**: - Short-term focus on B2B opportunities and bulk shipments, with long-term plans for branded product expansion in international markets [27] Management Philosophy - **Focus on Profitability**: The management team emphasizes profitability and cash flow generation, with a commitment to prudent capital allocation [25][26] Additional Important Information - **Market Share Fluctuations**: Auxly's market share can vary weekly but is generally around 6% [28] - **Debt Management**: The company has improved its balance sheet, ending Q3 with CAD 30 million in cash and a healthy debt-to-EBITDA ratio of 1.3 times [20] - **Product Launches**: Recent product launches, such as Southpoint, have shown strong initial market performance, with all SKUs ranking in the top 10 of their category shortly after launch [33] This summary encapsulates the key insights and strategic directions of Auxly Cannabis Group as discussed in the conference call.

Core Viewpoint - Investing in high-yielding dividend stocks is a strategic way to build wealth for retirement, emphasizing the importance of reinvesting dividends to compound earnings and grow the portfolio [1]. Group 1: Medical Properties Trust (MPW) - Medical Properties Trust has a dividend yield of 6.57% and operates as a triple net lease REIT, owning nearly 400 hospitals across nine countries, including the U.S. [6] - The stock price recently decreased from approximately $6.50 to $5.51 but is recovering after settling with bankrupt tenant Steward Health Care and addressing accusations from short sellers [7]. - Analysts at Collier Securities have upgraded MPW to a buy rating, indicating positive market sentiment [7]. Group 2: AFC Gamma (AFCG) - AFC Gamma offers a high yield of 21.58% as a commercial mortgage REIT, providing financing to the cannabis industry rather than acting as a landlord [9]. - The company’s dividend payout was $0.15 per share in Q3 2025, and it has gained momentum as cannabis legislation receives more support from the government [10]. - Shareholders approved a conversion from a mortgage REIT to a BDC, reflecting a strategic shift in the company's operations [10]. Group 3: Realty Income (O) - Realty Income has a yield of 5.6% and has consistently paid monthly dividends for several decades, with the latest distribution being $0.2695 per share as of November 2025 [13].

Group 1 - Tilray's stock price has significantly declined from a high of $23.15 on October 9 to $7.20 currently [1] - The stock price drop may continue to accelerate in the upcoming weeks [1] - A death cross pattern is approaching, indicating potential further declines in stock price [1]

Core Insights - Jeremy Szafron has joined Kitco News as an anchor and producer, bringing extensive experience in journalism, particularly in finance and current affairs [1][5] Background and Career Progression - Jeremy began his journalism career in 2006 at CTV, initially focusing on entertainment before transitioning to business reporting, particularly in mining and small-cap sectors [2] - He gained recognition for his macro-financial and market trends analysis, becoming a sought-after commentator on CTV Morning Live and CTV News Network [2] - A significant highlight of his career was covering the 2010 Vancouver Olympic Games, which led to the development of an online video news program for PressReader, a digital newsstand with 8,000 editions in 60 languages [3] Digital Media Ventures - In 2012, Jeremy launched The Green Scene Podcast, which quickly attracted over 400,000 subscribers, establishing him as a prominent voice in the cannabis industry [4] - Following this success, he created Investor Scene and Initiate Research, platforms that provide exclusive market insights and deal-flow opportunities in mining and Canadian small-cap markets [4] Professional Expertise - Jeremy has experience as a market strategist and investor relations consultant for various publicly traded companies across mining, energy, consumer packaged goods (CPG), and technology sectors [5] - He holds a BA in Journalism from Concordia University, which has supported his diverse career trajectory [5]

TALLAHASSEE, Fla., Dec. 8, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has received commitments for a private placement of 10.5% Senior Secured Notes due 2030 (the "Notes") for aggregate gross proceeds of US$100.0 million (the "Offering"). The Notes, which will be issued at 100% of face value, will be senior secured obligations of the Company. The Notes will bear int ...

Core Points - Trulieve Cannabis Corp. has completed the redemption of all US$368 million principal amount of its outstanding 8.0% senior secured notes due 2026, with a total cash outlay of approximately US$373 million [1] - The notes ceased trading on the Canadian Securities Exchange and were delisted as of December 5, 2025 [1] Company Overview - Trulieve is a leading vertically integrated cannabis company and multi-state operator in the U.S., with significant market positions in Arizona, Florida, and Pennsylvania [4] - The company is focused on accelerated growth and expansion through a hub strategy, enhancing retail and distribution capabilities in both new and existing markets [4] - Trulieve aims to provide innovative, high-quality products across its brand portfolio to improve customer experiences and increase access to cannabis [4]

Core Points - Avant Brands Inc. has fully repaid its $9.5 million amended and restated convertible debenture, which was originally issued in connection with the 2023 acquisition of 3PL Ventures Inc. [1] - The final payment was completed in November 2025, eliminating Avant's largest monthly recurring debt obligation [1] - This repayment strengthens the company's balance sheet and releases key operating assets from security [1]

Core Insights - Aurora Cannabis Inc. has appointed Kerry Miller as Managing Director for Australia and New Zealand, effective January 15, 2026, to drive growth in these markets [1][2] Group 1: Leadership Appointment - Kerry Miller brings 35 years of experience in consumer packaged goods, with a notable 25-year tenure at Reckitt Benckiser and nearly 10 years at Unilever, where he led global initiatives and transformation programs [3] - Miller expressed enthusiasm about joining Aurora at a pivotal moment for the company, focusing on expanding access to medical cannabis and enhancing innovation and partnerships [2] Group 2: Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company offers a diverse portfolio of brands, including adult-use brands like Drift and San Rafael '71, and medical brands such as MedReleaf and CanniMed [4] - Aurora also holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [4]